Dividend compounder review

ASND

Ascendis Pharma AS · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score48.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 15.5 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 18.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 8.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 7.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-228.0M
Free Cash Flow$45.4M
FCF Covers DividendUnknown
Debt / Equity1.84
P/E25.0
Revenue Growth 5Y150.9%
Net Margin57.3%
ROE3.3%
Price vs Trend-2.2%
3Y Return147.3%
5Y Return55.4%
CurrencyUSD
Warnings

Review flags

Price currency USD differs from financial currency EUR.
No usable dividend history found.
Dividend diary

Activity record

ASND dividend review warning Warning · Warning

No usable dividend history found.